176 related articles for article (PubMed ID: 12635615)
1. Policy shift. Bush's AIDS plan includes condom distribution, generic drugs.
AIDS Policy Law; 2003 Feb; 18(3):5. PubMed ID: 12635615
[No Abstract] [Full Text] [Related]
2. International. Rights group: U.S. blocking access to generic AIDS drugs.
AIDS Policy Law; 2004 Apr; 19(7):1, 4. PubMed ID: 15124593
[No Abstract] [Full Text] [Related]
3. [The patent legislation in India fails the HIV/AIDS work].
Holen Ø
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
[No Abstract] [Full Text] [Related]
4. World Trade Organization still threatens supply of affordable AIDS drugs.
Hagmann M
Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
[No Abstract] [Full Text] [Related]
5. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
Cohen J
Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
[No Abstract] [Full Text] [Related]
6. Production of low cost AIDS drugs to continue in Brazil.
Reprod Health Matters; 2001 Nov; 9(18):178. PubMed ID: 11803899
[No Abstract] [Full Text] [Related]
7. Physicians say generic AIDS drugs don't threaten R&D.
AIDS Policy Law; 2002 Mar; 17(6):4. PubMed ID: 12004757
[No Abstract] [Full Text] [Related]
8. Critics denounce Bush's proposed budget for HIV prevention and care.
AIDS Alert; 2002 Apr; 17(4):41, 43-5. PubMed ID: 12030198
[TBL] [Abstract][Full Text] [Related]
9. Is there a role for generic antiretroviral drugs in the United States?
Wormser GP; Lappas T
Expert Rev Anti Infect Ther; 2014 Aug; 12(8):897-9. PubMed ID: 24918192
[TBL] [Abstract][Full Text] [Related]
10. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
[No Abstract] [Full Text] [Related]
11. Canada's plan to sell generic drugs to developing countries is threatened.
Spurgeon D
BMJ; 2004 Mar; 328(7442):728. PubMed ID: 15044278
[No Abstract] [Full Text] [Related]
12. India: New patent law may restrict access to HIV/AIDS treatments.
Cruess G
HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971
[TBL] [Abstract][Full Text] [Related]
13. TRIPS: generic irony.
Howarth GR
Br J Gen Pract; 2002 Jan; 52(474):57. PubMed ID: 11791819
[No Abstract] [Full Text] [Related]
14. Kenya says yes to generic ARVs but fails to win Global Fund cash.
Njoroge J
Bull World Health Organ; 2002; 80(7):608. PubMed ID: 12163933
[No Abstract] [Full Text] [Related]
15. Generic HIV drugs will widen US treatment net.
Maxmen A
Nature; 2012 Aug; 488(7411):267. PubMed ID: 22895314
[No Abstract] [Full Text] [Related]
16. The future of generic HIV drugs in Rhode Island.
Lee JY; Reece R; Montague B; Rana A; Alexander-Scott N; Flanigan T
R I Med J (2013); 2013 Sep; 96(9):30-3. PubMed ID: 24015398
[TBL] [Abstract][Full Text] [Related]
17. Global fund decides to promote use of generic drugs.
Elliott R
Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):58-9. PubMed ID: 14740604
[No Abstract] [Full Text] [Related]
18. Affordable drug access for developing countries.
Highleyman L
BETA; 2001; 14(2):12-25. PubMed ID: 11785481
[No Abstract] [Full Text] [Related]
19. Generic drugs battle moves from South Africa to Kenya.
Siringi S
Lancet; 2001 May; 357(9268):1600. PubMed ID: 11377665
[No Abstract] [Full Text] [Related]
20. WHO pulls three more AIDS drugs from list.
Fleck F
BMJ; 2004 Aug; 329(7462):368. PubMed ID: 15310604
[No Abstract] [Full Text] [Related]
[Next] [New Search]